Cybin will leverage its 70 patents for breakthroughs in holistic depression treatment

BR

Invested

Community Contributor

Published

13 Feb 25

BrightSide's Fair Value

US$0

n/a

13 Feb

US$5.98

1Y

-32.8%

7D

-1.0%

Loading

1Y

-32.8%

7D

-1.0%

You can edit this narrative until May 14 2:39 AM. Then, changes will post as Updates.

Author's Valuation

US$0n/a

BrightSide's Fair Value

BrightSide'sFair Value

US$0

n/a

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

72.38%

Pharma revenue growth rate

0.64%